PMID- 29407008
OWN - NLM
STAT- MEDLINE
DCOM- 20181211
LR  - 20181211
IS  - 1916-7075 (Electronic)
IS  - 0828-282X (Linking)
VI  - 34
IP  - 2
DP  - 2018 Feb
TI  - Cardiac Intensive Care Unit Management of Patients After Cardiac Arrest: Now the 
      Real Work Begins.
PG  - 156-167
LID - S0828-282X(17)31175-3 [pii]
LID - 10.1016/j.cjca.2017.11.013 [doi]
AB  - Survival with a good quality of life after cardiac arrest continues to be
      abysmal. Coordinated resuscitative care does not end with the effective return of
      spontaneous circulation (ROSC)-in fact, quite the contrary is true. Along with
      identifying and appropriately treating the precipitating cause, various
      components of the post-cardiac arrest syndrome also require diligent observation 
      and management, including post-cardiac arrest neurologic injury and myocardial
      dysfunction, systemic ischemia-reperfusion phenomenon with potential consequent
      multiorgan failure, and the various sequelae of critical illness. There is
      growing evidence that an early invasive approach to coronary reperfusion with
      percutaneous coronary intervention, together with active targeted temperature
      management and optimization of hemodynamic, ventilator, and metabolic parameters,
      may improve survival and neurologic outcomes in cardiac arrest survivors.
      Neuroprognostication is complex, as are survivorship issues and long-term
      rehabilitation. Our paramedics, emergency physicians, and resuscitation
      specialists are all to be congratulated for ever-increasing success with ROSC... 
      but now the real work begins.
CI  - Copyright (c) 2017 Canadian Cardiovascular Society. Published by Elsevier Inc.
      All rights reserved.
FAU - Randhawa, Varinder K
AU  - Randhawa VK
AD  - Division of Cardiology, University of Toronto/University Health Network, Toronto,
      Ontario, Canada.
FAU - Grunau, Brian E
AU  - Grunau BE
AD  - Department of Emergency Medicine, St. Paul's Hospital, University of British
      Columbia, Vancouver, British Columbia, Canada.
FAU - Debicki, Derek B
AU  - Debicki DB
AD  - Department of Clinical Neurologic Sciences, Western University/London Health
      Sciences Centre, London, Ontario, Canada.
FAU - Zhou, Jian
AU  - Zhou J
AD  - Department of Anesthesia and Perioperative Medicine, Western University/London
      Health Sciences Centre, London, Ontario, Canada.
FAU - Hegazy, Ahmed F
AU  - Hegazy AF
AD  - Critical Care Western, Western University/London Health Sciences Centre, London, 
      Ontario, Canada; Department of Anesthesia and Perioperative Medicine, Western
      University/London Health Sciences Centre, London, Ontario, Canada.
FAU - McPherson, Terry
AU  - McPherson T
AD  - Division of Cardiology, Western University/London Health Sciences Centre, London,
      Ontario, Canada.
FAU - Nagpal, A Dave
AU  - Nagpal AD
AD  - Division of Cardiac Surgery, Western University/London Health Sciences Centre,
      London, Ontario, Canada; Critical Care Western, Western University/London Health 
      Sciences Centre, London, Ontario, Canada. Electronic address:
      dave.nagpal@lhsc.on.ca.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - England
TA  - Can J Cardiol
JT  - The Canadian journal of cardiology
JID - 8510280
RN  - 0 (Vasodilator Agents)
SB  - IM
MH  - Arrhythmias, Cardiac/therapy
MH  - Cognitive Dysfunction/prevention & control
MH  - Critical Care/*methods
MH  - Fluid Therapy
MH  - Heart Arrest/*therapy
MH  - Homeostasis
MH  - Humans
MH  - Hypothermia, Induced
MH  - Hypoxia, Brain/prevention & control
MH  - Infection Control
MH  - *Intensive Care Units
MH  - Multiple Organ Failure/prevention & control
MH  - Muscle Weakness/prevention & control
MH  - Myocardial Reperfusion
MH  - Neurophysiological Monitoring
MH  - Nutritional Support
MH  - Oxygen Inhalation Therapy
MH  - Pressure Ulcer/prevention & control
MH  - Regional Blood Flow
MH  - Respiration, Artificial
MH  - Respiratory Aspiration/prevention & control
MH  - Shock, Cardiogenic/diagnosis/therapy
MH  - Skin Care
MH  - Vasodilator Agents/therapeutic use
MH  - Venous Thrombosis/prevention & control
EDAT- 2018/02/07 06:00
MHDA- 2018/12/12 06:00
CRDT- 2018/02/07 06:00
PHST- 2017/10/16 00:00 [received]
PHST- 2017/11/22 00:00 [revised]
PHST- 2017/11/22 00:00 [accepted]
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/12/12 06:00 [medline]
AID - S0828-282X(17)31175-3 [pii]
AID - 10.1016/j.cjca.2017.11.013 [doi]
PST - ppublish
SO  - Can J Cardiol. 2018 Feb;34(2):156-167. doi: 10.1016/j.cjca.2017.11.013.